Anti-inflammatory effect of lucidone in mice via inhibition of NF-κB/MAP kinase pathway

International Immunopharmacology

Volumn 10, Issue 4, 2010, Pages 385-392

  Senthil Kumar, K J ^a   Hsieh, Han Wen ^a   Wang, Sheng Yang ^a  

^a Department of Forestry   (Taiwan)

Author keywords

Adaptor protein 1 (AP 1); Cyclooxygenase 2 (COX 2); Inducible nitric oxide synthase (iNOS); Lindera erythrocarpa; Lucidone; Nuclear factor B (NF B)

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LUCIDONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; DNA BINDING; DRUG BIOAVAILABILITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE TRANSLOCATION; LINDERA; LINDERA ERYTHROCARPA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; BLOTTING, WESTERN; CYCLOOXYGENASE 2 INHIBITORS; CYCLOPENTANES; DINOPROSTONE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; I-KAPPA B KINASE; INFLAMMATION; LINDERA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949489152     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.12.013     Document Type: Article

References (25)

1. Giuliani C., Napolitano G., Bucci I., Montani V., and Monaco F. Nf-kB transcription factor: role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications. Clin Ter 154 (2001) 249-253
2. Choi M.S., Lee S.H., Cho H.S., Kim Y., Yun Y.P., Jung H.Y., et al. Inhibitory effect of obovatol on nitric oxide production and activation of NF-κB/MAPK kinases in lipopolysaccharide-treated RAW 264.7 cells. Eur J Pharmacol 556 (2007) 181-189
3. Israf D.A., Khaizurin T.A., Lajis N.H., and Khozirah S. Cardamonin inhibits COX-2 and iNOS expression via inhibition of p65NF-κB nuclear translocation and Iκ-B phosphorylation in RAW 264.7 macrophage cells. Mol Immunology 44 (2007) 673-679
4. Tsai S.H., Lin-Shiau S.Y., and Lin J.K. Suppression of nitric oxide synthase and the down-regulation of the activation of NF-κB in macrophages by resveratrol. Br J Pharmacol 126 (1999) 673-680
5. Kim B.H., Cho S.M., Reddy A.M., Kim Y.S., Min K.R., and Kim Y. Down-regulatory effects of quercetin gallate on nuclear factor kappa B-dependent inducible nitric oxide synthase expression in lipopolysaccharide-stimulated macrophages RAW 264.7. Biochem Pharmacol 69 (2005) 1577-1583
6. Huh J.E., Yim J.H., Lee H.K., Moon E.Y., Rhee D.K., and Pyo S. Prodigiosin isolated from Hahella chejuensis suppresses lipopolysaccharide-induced NO production by inhibiting p38 MAPK, JNK and NF-κB activation in murine peritoneal macrophages. Inter Immuno Pharmacol 7 (2007) 1825-1833
7. Yang S.Y., Lambert J.D., Hou Z., Ju J., Lu G., and Hao X. Molecular targets for the cancer preventive activity of tea polyphenols. Mol Carcinog 45 (2006) 431-435
8. Lee H.H. The structure of lucidone and methyl lucidone. Tetrahedron Lett 9 (1968) 4243
9. Leong Y.W., Harrison L.J., Bennett G.J., Kadir A.A., and Connolly J.D. A dihydrochalcone from Lindera lucida. Phytochem 47 (1997) 891-894
10. Oh H.M., Chi S.K., Lee J.M., Lee S.K., Kim H.Y., Han D.C., et al. Cyclopentendiones inhibitors of farnesyl protein transferase and anti-tumor compounds, isolated from the fruits of Lindera erythrocarpa Makino. Bioorg and Med Chem 13 (2005) 6182-6187
11. Wang S.Y., Lan X.Y., Xiao J.-H., Yang J.C., Kao Y.T., and Chang S.T. Anti-inflammatory activity of Lindera erythrocarpa fruits. Phytotherapy Res 22 (2008) 213-216
12. Senthil Kumar K.J., and Wang S.Y. Lucidone inhibits iNOS and COX-2 expression in LPS-induced RAW 264.7 murine macrophage cells via NF-κB and MAPKs signaling pathways. Planta medica 75 (2009) 494-500
13. Lotter K., Hocherl K., Bucher M., and Kees F. In vivo efficacy of telithromycin on cytokine and nitric oxide formation in lipopolysaccharide-induced acute systemic inflammation in mice. J Antimicrob Chemother 58 (2006) 615-621
14. Miranda K.M., Espey G.M., and Wink D.A. A rapid, simple photometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5 (2001) 62-71
15. 2 in vitro or in mouse skin. Br J Pharmacol 2005;46:352-63.
16. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Muhammad J., Zweifel B.S., et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 480 1 (2001) 243-268
17. Choy C.S., Hu C.M., Chiu W.T., Kei Lam C.S., Ting Y., Tsai S.H., et al. Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells. J Ethno Pharmacol 115 (2008) 455-462
18. Jarrar D., Kuebler J.F., Rue L.W., Matalon S., Wang P., Bland K.I., et al. Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-κB and MAPK/ERK mechanisms. Amer J Physiol 283 (2002) L799-L805
19. Zang G., and Ghosh S. Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res 6 (2000) 453-457
20. Tanaka A., Hase S., Miyazawa T., Ohno R., and Takeuchi K. Role of cyclooxygenase COX-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. J Pharmacol Expri Therapeutic 303 (2002) 1248-1254
21. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappaB/Rel in induction of nitric oxide synthase. J Biol Chem 269 (1994) 4705-4708
22. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90 (1993) 9730-9734
23. Grandjean-Laquerriere A., Gangloff S.C., Le Naour R., Trentesaux C., Hornebeck W., and Guenounou M. Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18 (2002) 168-177
24. Park J.S., Lee E.J., Lee J.C., Kim W.K., and Kim H.S. Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells: Involvement of NF-κB and ERK signaling pathways. Inter Immuno Pharmacol 7 (2007) 70-77
25. Kundu J.K., and Surh Y.J. Breaking the relay in deregulated cellular signal transduction as a rationale for chemo prevention with anti-inflammatory phytochemicals. Mutation Res 591 (2005) 123-146